Theravance Biopharma Inc (TBPH) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $18.19
• Market Cap: $965.82M
• P/E Ratio: 33.44
• EPS: $0.57
• 52-Week High: $21.03
• 52-Week Low: $7.90

Market Sentiment

Theravance Biopharma Inc currently has a Bullish sentiment score of 0.37.

About Theravance Biopharma Inc

Theravance Biopharma, Inc. (TBPH) is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative organ-selective drugs aimed at addressing significant unmet medical needs. With a strategic emphasis on respiratory diseases and conditions, Theravance leverages its proprietary technologies and deep scientific expertise to bring novel therapies to market, enhancing patient outcomes worldwide. Headquartered in George Town, Cayman Islands, the company oper...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Theravance Biopharma Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does TBPH pay dividends?

Theravance Biopharma Inc (TBPH) does not currently pay a regular dividend.

What is TBPH's P/E ratio?

Theravance Biopharma Inc has a price-to-earnings (P/E) ratio of 33.44.

What is TBPH's market cap?

Theravance Biopharma Inc (TBPH) has a market capitalization of $965.82M with a current stock price of $18.19.